This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
and operates the TANAKA Precious Metals manufacturing business, announced today that TANAKA made an equity contribution to Ambix LifeScience Fund I, L.P., The post TANAKA Contributes to Ambix LifeScience Fund appeared first on Pharma Mirror Magazine. Background to and Objectives.
From enabling patient choice during clinical trials to strengthening vital partnerships across the quality ecosystem, connected data will become the lifeblood that enables lifesciences teams to collaborate efficiently and effectively in 2023. Simplicity and technology intersect to streamline drug development.
This episode features an interview with Yang Liu, PhD, founder, chairman, CEO and chief scientific officer; and Abid Ansari, MBA, Chief Financial Officer at OncoC4 , a clinical-stage biopharmaceutical company focused on developing novel treatments for cancer. Subscribe to the Xtalks LifeScience Podcast to never miss a new episode.
Monogram is focused on developing patient-optimized orthopedic implants at scale by linking 3D printing and robotics with advanced pre-operative imaging. Ben is an engineer by training and before joining Monogram, he served as the Director of BusinessDevelopment at Pro-Dex, an OEM manufacturer of Orthopedic Robotic End-Effectors.
How did you get into lifesciences? After a few years, I decided I wanted to move into the commercial side of the business, so I completed an MBA and went on to hold various positions in Corporate BusinessDevelopment, LifeScience and Healthcare. What has your career path been?
New and existing investors including F-Prime Capital, Altitude LifeScience Ventures, Mubadala Capital, Amgen, Exor Ventures, ARCH Venture Partners, Invus, Abu Dhabi Growth Fund (ADG), Newpath Partners, Polaris Partners, as well as other undisclosed investors have participated in the financing round.
The company claimed to have developed a revolutionary blood testing technology that could detect a wide range of diseases with just a few drops of blood. Theranos’ groundbreaking developments received many patents. Lifescience startups face unique challenges given the highly regulated and complex nature of the industry.
PTC Therapeutics has signed a strategic financing partnership worth up to $1bn with funds managed by Blackstone to back the development of the former’s innovative product pipeline. PTC will use the network and lifesciences capabilities of Blackstone to expand its businessdevelopment works.
1910 Genetics, a biotechnology company integrating artificial intelligence (AI), computation and biological automation to accelerate the design of small molecule and protein therapeutics, has appointed Patrick Genestin as chief business officer. .” Patrick Genestin, 1910 Genetics .
Every year, Fierce’s pharma, biotech, and medtech teams come together to spotlight some of the fiercest women in life s | This week on "The Top Line," Fierce editors discuss our special report celebrating 10 women driving change in clinical research, businessdevelopment, venture capital, and more
Reno, NV, June 27, 2022 — Crucial Data Solutions (CDS), a provider of innovative low-code/no-code technologies to advance clinical research, announced today that industry veteran Brian Dufrense has joined the company as Senior Vice President, BusinessDevelopment.
The Healthcare Businesswoman’s Association Europe region released an update to its 2018 industry gender pay gap report that shows there is a clear increase in the pay gap between men and women in the lifesciences sector in Europe. France and the U.K. reduced the pay gap to 4.8 percent and 5.1 Get the Full Report.
Oftentimes as clinical research professionals we do not think of ourselves as sales people but expanding your opportunities in the lifesciences industry is as important as anything else we will ever do for our careers.
Blueprint Medicines has entered strategic financing partnerships for up to $1.25bn with lifesciences-focused investors Sixth Street and Royalty Pharma. The funding will offer capital to extend Blueprint’s varied pipeline toward marketing as well as to continue seeking strategic and synergistic businessdevelopment prospects.
Now, he leads Whitelab Genomics as its artificial intelligence (AI) platform powers the development of genomic therapies – an emerging field in which genetic sequences are injected into cells to target and repair damaged genes. We have been very impressed by their vision and the relevance of their platform.”.
In this week’s Xtalks LifeScience podcast episode, Ayesha and the editorial team spoke with Susan Benton, Country Manager at Thea Pharma, an eye care company that focuses on developing innovative eye care treatments to help further the future of ophthalmic treatment. Susan Benton Country Manager Thea Pharma Inc.
180 LifeSciences Corp. Vu Chief Operating Officer/Chief Business Officer 180 LifeSciences Corp. Vu Chief Operating Officer/Chief Business Officer Highly Accomplished Strategy, Corporate/BusinessDevelopment, Finance and Operations Executive With 20 Years of Biopharma … Continue reading →
The list includes, but is not limited to, the providers of shipping and logistics for medical devices, diagnostics and lifescience products, cold chain logistics, storage and terminal services, value-added and financial services, trucking options for manufacturers, and digitalised pharmaceutical supply chain for improved visibility.
Lifesciences marketing has rapidly evolved to mirror that of consumer retail. It may not be surprising that the key to customer engagement optimisation, like many other processes within lifesciences operations, is orchestrated data management and analysis. Automatic HCP segmentation HCPs change segments regularly.
As many strive to bring about transformation in healthcare, Angelini Ventures takes a new approach to investments in digital health and lifesciences companies that drive healthcare innovation and improve patient experiences. It aims to shape companies in the digital healthcare, connected medical devices, and lifesciences spaces.
So, working together with patients, research clinicians and Pfizer, the NIHR has collectively agreed a way in which it can facilitate patient engagement, remain aligned with ABPI and AMRC Codes and help to manage the burden faced by lifesciences companies. How the NIHR’s Patient Engagement in Clinical Development service can help.
In this penultimate instalment of the five-part, festive series of the pharmaphorum podcast, host Nicole Raleigh speaks with Bobby Savarese, senior principal and businessdevelopment director at Unispace LifeSciences, exploring how laboratory space requirements have changed since the pandemic.
He began his career in businessdevelopment and commercial strategy roles at Genentech. Subscribe to the Xtalks LifeScience Podcast to never miss a new episode. Cody Simmons, CEO, DermaSensor As a bioengineer and entrepreneur, Cody has spent all of his career bringing new health technologies to physicians and patients.
(HP&M), a leader in providing legal and regulatory support to the lifesciences industries, today announced the appointment of Jeff Grizzel to the newly created position of Chief Marketing Officer (CMO). Jeff joins HP&M from Compliance Architects where he served as Vice President of BusinessDevelopment.
David Clifton is professor of clinical machine learning in the Department of Engineering Science of the University of Oxford. His research focuses on the development of big data machine learning for tracking the health of complex systems. Mark holds a PhD in biomedicine, and an MSc in biostatistics.
For the past year, lifescience companies around the world worked at breakneck speed to develop and manufacture safe and effective treatments to respond to the COVID-19 pandemic. Basak, is a senior lifesciences specialist at IFC, the arm of the World Bank Group investing in the private sectors in emerging markets.
Today’s guest post comes from Stacey Little, Senior Vice President of BusinessDevelopment and Marketing at AssistRx. Stacey provides five crucial questions to help lifescience companies evaluate providers of patient support programs (PSPs).
Breithaupt has been integral in building the media services department — hiring talent, developing media resources, and growing Intouch’s client roster, as well as evolving media capabilities and applying a pharma lens to her work. Collectively, Intouch Group employs more than 1,400 people.
With this acquisition, Calibre Scientific bolsters its strength in the chromatography market and continues to broaden its lifesciences presence in Europe. With the acquisition of AIT, Calibre Scientific gains a strategic partner to continue its growth in lifesciences. LOS ANGELES, Jan. About Calibre Scientific.
Once a staunch devotee of the diversified lifesciencesbusiness model, Novartis has been steadily trimming down its focus in recent years, cashing in non-core business to generate billions of dollars and reinvesting the proceeds in its pharma R&D pipeline.
Cloudbyz, a fast-growing integrated Clinical Research and development solution provider in Healthcare & LifeScience, has recently executed a CSR drive at the Samarthanam Trust for the Disabled showcasing its commitment to social responsibility by giving back to the community. About the Cloudbyz.
Gain a comprehensive understanding of Hatch-Waxman and BPCIA essentials—critical competencies for legal and business professionals in the biopharmaceutical sector. Everyone in the lifesciences industry must be well-versed in the regulatory components and intellectual property nuances integral to patenting products.
After making her way from early-stage drug development research to her current role, Heather got straight to work on creating sustainable collaborations that made life better for people and their families. “I I am fascinated by the breadth of my role, which encompasses self-care products, skin health, sustainability and much more.
One is the platform, which is essentially what our internal solution developers capitalise on, and then we externalise that capability to third-party developers.”. External developers can use Komodo’s platform and build analytics modules to explore other use cases using low code or no-code environments. The business of data.
No more ‘business as usual’ for pharma’s customer engagement. Lifesciences companies need to rethink their customer engagement paradigms in light of changing customer preferences. Gerry Chillè is senior partner at Healthware Group, in charge of its digital therapeutics pipeline strategy and development.
Xtalks spoke with Richard Philipson, MD, Chief Medical Officer (CMO) at Calliditas Therapeutics, a Sweden-based company with full commercial operations in the US focused on developing treatments for rare diseases to learn more about the continuing evolution of rare disease drug development.
In a recent webinar from pharmaphorum, the National Institute for Health Research (NIHR) outlined why and how it has developed a new approach to engage with patients while complying with national regulations, such as those set out in the Association of the British Pharmaceutical Industry’s (ABPI) Code of Practice.
Gain a comprehensive understanding of Hatch-Waxman and BPCIA essentials AND a critical competency for legal and business professionals in the biopharmaceutical arena AT THE American Conference Institute’s (ACI’s) 3rd Annual Passport to Proficiency on the Essentials of Hatch-Waxman and BPCIA ! This year’s co-chairs include Li Feng, Ph.D.
The company has partnered with lifesciences-focused investors Sixth Street and Royalty Pharma with an aim to bring substantial non-dilutive, low-cost capital to boost innovation and growth. What all the ranked entities have in common is the demonstration of new concepts not just within their own business but in the sector as a whole.
Aaron Gani, founder and CEO of BehaVR, and Krys Zaluski, director of businessdevelopment, digital health at Sumitomo Dainippon Pharma, discuss their groundbreaking partnership to develop and commercialise digital therapeutics (DTx) products. . “Our capabilities are very complimentary. About the author .
It’s all change at Alphabet’s lifesciencesbusiness Verily, with a $1 billion funding round and a shake-up of its senior leadership, including a new chief executive and executive chairman, who will have to decide how to spend the new money. Verily’s Andrew Conrad.
We will continue to focus on supporting new launches, expanding our manufacturing capacity and advancing our pipeline through research and development and businessdevelopment, said Lucas Montarce, Lilly executive vice president and chief financial officer, in a press release announcing the share buyback program.
On 14th November, investors and lifescience & healthcare executives descended on London’s famed Old Billingsgate building to attend LSX’s Inv€$tival Showcase, part of Europe’s biggest dedicated healthcare investment week. Investing in the future of the European lifesciences.
13, 2021 (GLOBE NEWSWIRE) — Tiziana LifeSciences plc (Nasdaq: TLSA / AIM: TILS) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infectious diseases, announces the appointment of Dr Neil Graham MBBS, MD, MPH as Chief Medical Officer.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content